Shanghai INT Medical's Profit Inches Up in 2025; Shares Climb 6%

MT Newswires Live03-30

Shanghai INT Medical Instruments (HKG:1501) recorded a rise in attributable profit in 2025 to 218.8 million yuan from 191.9 million yuan a year prior, according to a March 27 Hong Kong bourse filing.

Shares of the medical device maker were up nearly 6% in Monday afternoon trading.

Earnings per share rose to 1.26 yuan from 1.10 yuan in the previous fiscal year.

Revenue increased 25% to 1.07 billion yuan from 852 million yuan in the year-ago period, mainly due to a higher number of new customers.

The company recommended a final dividend of 0.23 yuan per share for the year, payable on or around June 30 to shareholders of record on June 10.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment